BMNR is trading at 4.4% up now at $32.33 after a sharp three-day decline that saw the stock fall over 25% from November 13 to November 17, 2025. The rebound follows a period of heavy selling and high volatility, with recent insider and institutional buying activity noted. Major hedge funds, including Morgan Stanley and ARK Investment Management, significantly increased their positions in Q3 2025. While no major company-specific news was announced today, the stock's recovery appears to be driven by oversold conditions and continued institutional support, rather than a single catalyst.